ArticlePloS one2025
IDQuAD: Infectious disease question and answering dataset.
Article in PloS one, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
While large language models (LLMs) have made significant advances in various fields, The study of applying LLMs to infectious disease-specific tasks has lagged behind. This study addresses this gap by introducing the Infectious Disease Question and Answering Dataset (IDQuAD), which is a novel dataset designed to train and evaluate LLMs in infectious disease-related queries. IDQuAD is constructed using medical papers, patents, and news, and employs innovative methodologies such as generating answers before questions and using counterfactual thinking to enhance the quality of the Question Answering (QA) pairs. In the experimental phase, we fine-tuned the Mistral-7B model on the IDQuAD dataset to test the effectiveness of our proposed datasets on LLM performance in QA tasks related to infectious diseases. The fine-tuned Mistral-7B model demonstrated substantial performance improvements, with its EM score increasing from 28.49% to 65.47% in the one-shot setting. Additionally, we evaluated other LLMs across various setups. Among all models tested, our fine-tuned model achieved the highest performance across metrics and settings. In conclusion, this study introduces IDQuAD as a foundational dataset for infectious disease research, demonstrating the effectiveness of fine-tuning LLMs and paving the way for future advances in dataset development and LLM refinement for infectious disease tasks.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.